Core Laboratories NV Stock News

Core Laboratories (NYSE:CLB) had its price target cut by equities research analysts at Citigroup from $40.00 to $11.00 in a research note issued on Friday, BenzingaRatingsTable reports. The brokerage

Gainers CorePoint Lodging Inc. (NYSE: CPLG) gained 55.6% to $5.29 after the company reported results for its fourth quarter. OPKO Health, Inc. (NASDAQ: OPK) climbed 44.4% to $2....

Gainers Ranger Energy Services, Inc. (NYSE: RNGR) shares rose 44.8% to close at $4.46 on Thursday. Ampco-Pittsburgh Corporation (NYSE: AP) shares surged 35.6% to close at $3.20...

It's another brutal day in the oil market.

Core Laboratories (NYSE:CLB)’s stock price hit a new 52-week low during mid-day trading on Wednesday after Stifel Nicolaus lowered their price target on the stock from $40.00 to $17.00. Stifel Nicol

Plunging oil prices and the economic impact of the coronavirus could prompt a potential wave of debt restructurings and bankruptcies, especially in the energy and services sectors, analysts say.Oasis

It's another brutal day in the oil market.

During Wednesday's morning session, 690 stocks hit new 52-week lows. Intriguing Points: Boeing (NYSE: BA) was the biggest company on a market cap basis to set a new...

Core Laboratories (NYSE:CLB) was downgraded by research analysts at Bank of America from a “buy” rating to an “underperform” rating in a note issued to investors on Monday, Marketbeat reports.

Core Laboratories (NYSE:CLB) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Monday, ValuEngine reports. A number

Shares of Core Laboratories (NYSE:CLB) gapped down before the market opened on Tuesday after Stifel Nicolaus lowered their price target on the stock from $40.00 to $17.00. The stock had previously clo

Plummeting oil prices and uncertainty around the oil market in the midst of a price war between two big producing nations led Bank of America to downgrade nearly every stock in the sector that it didn

Stifel Nicolaus analyst Stephen Gengaro maintained a Hold rating on Core Laboratories (CLB) today and set a price target of $17.00. The company's shares